Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bayard Clarkson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Disorders

Chemicals & Drugs

Physiology

Cell Division

Procedures

Concepts & Ideas

Time Factors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
39
Strife, Annabel
34
Wisniewski, David
19
Moore, Malcolm
18
Chaganti, Raju
17
Straus, David
17
Veach, Darren
15
Berman, Ellin
14
Atzpodien, Jens
14
Jhanwar, Suresh
13
Bornmann, William
10
Shimazaki, Chihiro
9
O'Reilly, Richard
8
Yahalom, Joachim
7
Reich, Lilian
6
Scheinberg, David

Sign-in to see all Coauthors

Publications

TOP 3
Antczak Christophe; Veach Darren R; Ramirez Christina N; Minchenko Maria A; Shum David; Calder Paul A; Frattini Mark G; Clarkson Bayard; Djaballah Hakim
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.
Foo Jasmine; Drummond Mark W; Clarkson Bayard; Holyoake Tessa; Michor Franziska
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.
Wu Ding; Mand Michael R; Veach Darren R; Parker Laurie L; Clarkson Bayard; Kron Stephen J
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bayard Clarkson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Antczak Christophe; Veach Darren R; Ramirez Christina N; Minchenko Maria A; Shum David; Calder Paul A; Frattini Mark G; Clarkson Bayard; Djaballah Hakim
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.
Bioorganic & medicinal chemistry letters 2009;19(24):6872-6.
2009: Foo Jasmine; Drummond Mark W; Clarkson Bayard; Holyoake Tessa; Michor Franziska
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.
PLoS computational biology 2009;5(9):e1000503.
2008: Wu Ding; Mand Michael R; Veach Darren R; Parker Laurie L; Clarkson Bayard; Kron Stephen J
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates.
Analytical biochemistry 2008;375(1):18-26.
2007: Gao Sizhi Paul; Mark Kevin G; Leslie Kenneth; Pao William; Motoi Noriko; Gerald William L; Travis William D; Bornmann William; Veach Darren; Clarkson Bayard; Bromberg Jacqueline F
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
The Journal of clinical investigation 2007;117(12):3846-56.
2007: Veach Darren R; Namavari Mohammad; Pillarsetty Nagavarakishore; Santos Elmer B; Beresten-Kochetkov Tatiana; Lambek Caryl; Punzalan Blesida J; Antczak Christophe; Smith-Jones Peter M; Djaballah Hakim; Clarkson Bayard; Larson Steven M
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.
Journal of medicinal chemistry 2007;50(23):5853-7.
2007: Guo Tianhua; Agaram Narasimhan P; Wong Grace C; Hom Glory; D'Adamo David; Maki Robert G; Schwartz Gary K; Veach Darren; Clarkson Bayard D; Singer Samuel; DeMatteo Ronald P; Besmer Peter; Antonescu Cristina R
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4874-81.
2007: Antonescu Cristina R; Busam Klaus J; Francone Todd D; Wong Grace C; Guo Tianhua; Agaram Narasimhan P; Besmer Peter; Jungbluth Achim; Gimbel Mark; Chen Chin-Tung; Veach Darren; Clarkson Bayard D; Paty Philip B; Weiser Martin R
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
International journal of cancer. Journal international du cancer 2007;121(2):257-64.
2006: Liang Xiquan; Hajivandi Mahbod; Veach Darren; Wisniewski David; Clarkson Bayard; Resh Marilyn D; Pope R Marshall
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
Proteomics 2006;6(16):4554-64.
2006: Azam Mohammad; Nardi Valentina; Shakespeare William C; Metcalf Chester A; Bohacek Regine S; Wang Yihan; Sundaramoorthi Raji; Sliz Piotr; Veach Darren R; Bornmann William G; Clarkson Bayard; Dalgarno David C; Sawyer Tomi K; Daley George Q
Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9244-9.
2006: Wendel Hans-Guido; de Stanchina Elisa; Cepero Enriqué; Ray Sagarika; Emig Michael; Fridman Jordan S; Veach Darren R; Bornmann William G; Clarkson Bayard; McCombie W Richard; Kogan Scott C; Hochhaus Andreas; Lowe Scott W
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(19):7444-9.
2005: Veach Darren R; Namavari Mohammad; Beresten Tatiana; Balatoni Julius; Minchenko Maria; Djaballah Hakim; Finn Ronald D; Clarkson Bayard; Gelovani Juri G; Bornmann William G; Larson Steven M
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.
Nuclear medicine and biology 2005;32(4):313-21.
2005: Wolff Nicholas C; Veach Darren R; Tong William P; Bornmann William G; Clarkson Bayard; Ilaria Robert L
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Blood 2005;105(10):3995-4003.
2005: von Bubnoff Nikolas; Veach Darren R; van der Kuip Heiko; Aulitzky Walter E; Sänger Jana; Seipel Petra; Bornmann William G; Peschel Christian; Clarkson Bayard; Duyster Justus
A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor.
Blood 2005;105(4):1652-9.
2004: Deng Xinzhu; Hofmann E Randal; Villanueva Alberto; Hobert Oliver; Capodieci Paola; Veach Darren R; Yin Xianglei; Campodonico Luis; Glekas Athanasios; Cordon-Cardo Carlos; Clarkson Bayard; Bornmann William G; Fuks Zvi; Hengartner Michael O; Kolesnick Richard
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation.
Nature genetics 2004;36(8):906-12.
2003: von Bubnoff Nikolas; Veach Darren R; Miller W Todd; Li Wanqing; Sänger Jana; Peschel Christian; Bornmann William G; Clarkson Bayard; Duyster Justus
Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors.
Cancer research 2003;63(19):6395-404.
2003: Netzer William J; Dou Fei; Cai Dongming; Veach Darren; Jean Stephanie; Li Yueming; Bornmann William G; Clarkson Bayard; Xu Huaxi; Greengard Paul
Gleevec inhibits beta-amyloid production but not Notch cleavage.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(21):12444-9.
2003: Clarkson B; Strife A; Wisniewski D; Lambek C L; Liu C
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(7):1211-62.
2003: Nagar Bhushan; Hantschel Oliver; Young Matthew A; Scheffzek Klaus; Veach Darren; Bornmann William; Clarkson Bayard; Superti-Furga Giulio; Kuriyan John
Structural basis for the autoinhibition of c-Abl tyrosine kinase.
Cell 2003;112(6):859-71.
2003: Strife Annabel; Wisniewski David; Liu Chongyuan; Lambek Caryl L; Darzynkiewicz Zbigniew; Silver Richard T; Clarkson Bayard
Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
Molecular cancer research : MCR 2003;1(3):176-85.
2002: Wisniewski David; Lambek Caryl L; Liu Chongyuan; Strife Annabel; Veach Darren R; Nagar Bhushan; Young Matthew A; Schindler Thomas; Bornmann William G; Bertino Joseph R; Kuriyan John; Clarkson Bayard
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Cancer research 2002;62(15):4244-55.
2002: Nagar Bhushan; Bornmann William G; Pellicena Patricia; Schindler Thomas; Veach Darren R; Miller W Todd; Clarkson Bayard; Kuriyan John
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
Cancer research 2002;62(15):4236-43.
2002: Clarkson Bayard
Treatment of preschool OCD.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(4):363; author reply 363.
2002: Liang Xiquan; Wisniewski David; Strife Annabel; Shivakrupa; Clarkson Bayard; Resh Marilyn D
Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.
The Journal of biological chemistry 2002;277(16):13732-8.
2001: Di Cristofano A; Niki M; Zhao M; Karnell F G; Clarkson B; Pear W S; Van Aelst L; Pandolfi P P
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
The Journal of experimental medicine 2001;194(3):275-84.
2000: Schindler T; Bornmann W; Pellicena P; Miller W T; Clarkson B; Kuriyan J
Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.
Science (New York, N.Y.) 2000;289(5486):1938-42.
2000: Dunant N M; Wisniewski D; Strife A; Clarkson B; Resh M D
The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
Cellular signalling 2000;12(5):317-26.
2000: Berman E; Jhanwar S; McBride M; Strife A; Wisniewski D; Lambek C; Clarkson B
Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL).
Leukemia research 2000;24(4):289-97.
1999: Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh W M; Tempst P; Clarkson B
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Blood 1999;93(8):2707-20.
1998: Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi P P; Resh M D
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.
The Journal of biological chemistry 1998;273(9):4827-30.
1997: Clarkson B D; Strife A; Wisniewski D; Lambek C; Carpino N
New understanding of the pathogenesis of CML: a prototype of early neoplasia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(9):1404-28.
1997: Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Cell 1997;88(2):197-204.
1996: Wisniewski D; Strife A; Clarkson B
c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(9):1436-42.
1996: Wisniewski D; Strife A; Berman E; Clarkson B
c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(2):229-37.
1995: Clarkson B; Chabner B A; Weinberg R A
Targets for specific therapies in leukemia.
Cancer research 1995;55(19):4488-98.
1994: Clarkson B
Specific genetic defects as targets for selective therapies. Commentary.
Current opinion in hematology 1994;1(4):235-47.
1994: Cervantes F; Robertson J E; Rozman C; Baccarani M; Tura S; Gómez G A; Braun T J; Clarkson B D; Pereira A
Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.
British journal of haematology 1994;87(2):293-300.
1994: Tafuri A; Lemoli R M; Chen R; Gulati S C; Clarkson B D; Andreeff M
Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(5):749-57.
1994: Wisniewski D; Strife A; Wojciechowicz D; Lambek C; Clarkson B
A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(4):688-93.
1993: Clarkson B; Strife A
Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(11):1683-721.
1993: Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand.
Leukemia research 1993;17(9):799-807.
1993: Yahalom J; Varsos G; Fuks Z; Myers J; Clarkson B D; Straus D J
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
Cancer 1993;71(7):2342-50.
1993: Gold J; Shera D; Clarkson B
Private psychiatric hospitalization of children: predictors of length of stay.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32(1):135-43.
1993: Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Cancer research 1993;53(2):401-9.
1993: Clarkson B; Strife A
Cytokinetic considerations relevant to development of a successful therapeutic strategy in chronic myelogenous leukemia (CML).
Leukemia & lymphoma 1993;11 Suppl 1():101-7.
1993: Clarkson B; Strife A; Perez A; Lambek C; Wisniewski D
Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML).
Leukemia & lymphoma 1993;11 Suppl 2():81-100.
1992: Lemoli R M; Strife A; Clarkson B D; Haley J D; Gulati S C
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Experimental hematology 1992;20(11):1252-6.
1992: Clarkson B D
Consistent genetic abnormalities in human cancers as targets for selective therapies.
The Mount Sinai journal of medicine, New York 1992;59(5):400-4.
1992: Gulati S; Acaba L; Yahalom J; Reich L; Motzer R; Crown J; Doherty M; Clarkson B; Berman E; Atzpodien J
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
Bone marrow transplantation 1992;10(2):129-34.
1992: al-Katib A; Wang C Y; McKenzie S; Clarkson B D; Koziner B
Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
American journal of hematology 1992;40(4):264-9.
1992: Kolitz J E; Kempin S J; Schluger A; Wong G Y; Berman E; Jhanwar S; Arlin Z A; Gee T; Clarkson B D
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.
Seminars in oncology 1992;19(3 Suppl 9):27-33.
1992: Lemoli R M; Tafuri A; Strife A; Andreeff M; Clarkson B D; Gulati S C
Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors.
Experimental hematology 1992;20(5):569-75.
1992: Rivas C I; Wisniewski D; Strife A; Perez A; Lambek C; Bruno S; Darzynkiewicz Z; Clarkson B
Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.
Blood 1992;79(8):1982-6.
1992: Berman E; Little C; Gee T; O'Reilly R; Clarkson B
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.
The New England journal of medicine 1992;326(3):156-60.
1991: Yahalom J; Ryu J; Straus D J; Gaynor J J; Myers J; Caravelli J; Clarkson B D; Fuks Z
Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2193-201.
1991: Berman E; Strife A; Wisniewski D; Desai S; Gulati S; Jhanwar S; Clarkson B D
Duration of the preclinical phase of chronic myelogenous leukemia: a case report.
Blood 1991;78(11):2969-72.
1991: Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley J D; ten Dijke P; Iwata K K; Clarkson B D
The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Cancer research 1991;51(18):4828-36.
1991: Clarkson B
New pharmacologic approaches to treatment of leukemia.
Seminars in hematology 1991;28(3 Suppl 4):99-115.
1991: Berman E; Weiss M; Kempin S; Gee T; Bertino J; Clarkson B
Intensive therapy for adult acute lymphoblastic leukemia.
Seminars in hematology 1991;28(3 Suppl 4):72-5.
1991: Clarkson B
Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1991;3(6):211-20.
1991: Lemoli R M; Gulati S C; Strife A; Lambek C; Perez A; Clarkson B D
Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(5):386-91.
1991: Lemoli R M; Gasparetto C; Scheinberg D A; Moore M A; Clarkson B D; Gulati S C
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Blood 1991;77(8):1829-36.
1991: Fokas A S; Keller J B; Clarkson B D
Mathematical model of granulocytopoiesis and chronic myelogenous leukemia.
Cancer research 1991;51(8):2084-91.
1991: Straus D J; Wong G Y; Liu J; Oppenberg J; Filippa D A; Gold J W; Offit K; Clarkson B D
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.
The American journal of medicine 1991;90(3):328-37.
1991: Scheinberg D A; Lovett D; Divgi C R; Graham M C; Berman E; Pentlow K; Feirt N; Finn R D; Clarkson B D; Gee T S
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):478-90.
1991: Berman E; Adams M; Duigou-Osterndorf R; Godfrey L; Clarkson B; Andreeff M
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype.
Blood 1991;77(4):818-25.
1991: Gulati S C; Yahalom J; Whitmarsh K; Clarkson B D; Gee T
Factors affecting the outcome of autologous bone marrow transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():51-5.
1991: Wisniewski D; Strife A; Clarkson B
Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.
Leukemia research 1991;15(9):867-74.
1991: Straus D J; Wong G; Yahalom J; Varsos G; Gulati S; Clarkson B
Diffuse large cell lymphoma. Prognostic factors with treatment.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5 Suppl 1():32-7.
1990: Straus D J; Gaynor J J; Myers J; Merke D P; Caravelli J; Chapman D; Yahalom J; Clarkson B D
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1173-86.
1990: Berman E; Heller G; Kempin S; Gee T; Tran L L; Clarkson B
Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
Blood 1990;75(4):839-45.
1990: Schneider A M; Straus D J; Schluger A E; Lowenthal D A; Koziner B; Lee B J; Wong G; Clarkson B D
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):94-102.
1990: Shimazaki C; Inaba T; Murakami S; Fujita N; Nakagawa M; Gulati S C; Fried J; Clarkson B D; Wisniewolski R; Wang C Y
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Progress in clinical and biological research 1990;333():311-9.
1990: Schneller F R; Gulati S C; Cunningham I B; O'Reilly R J; Schmitt H J; Clarkson B D
Fusarium infections in patients with hematologic malignancies.
Leukemia research 1990;14(11-12):961-6.
1990: Lemoli R M; Gulati S C; Perez A; Clarkson B D
Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119.
Cancer communications 1990;2(2):87-91.
1990: Clarkson B; Gaynor J; Little C; Berman E; Kempin S; Andreeff M; Gulati S; Cunningham I; Gee T
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():397-408.
1990: Gulati S; Atzpodien J; Lemoli R M; Shimazaki C; Clarkson B
Photoradiation methods for purging autologous bone marrow grafts.
Progress in clinical and biological research 1990;333():87-102.
1990: Shimazaki C; Fried J; Perez A G; Scheinberg D A; Atzpodien J; Wang C Y; Wisniewolski R; Clarkson B D
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Acta haematologica 1990;83(3):123-9.
1989: Gulati S C; Whitmarsh K; Reich L; Berman E; Yahalom J; Yopp J; Clarkson B; Gee T
Results of autologous bone marrow transplantation for acute leukaemia.
Bone marrow transplantation 1989;4 Suppl 4():61-4.
1989: Offit K; Jhanwar S; Ebrahim S A; Filippa D; Clarkson B D; Chaganti R S
t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma.
Blood 1989;74(6):1876-9.
1989: Yahalom J; Gulati S; Shank B; Clarkson B; Fuks Z
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
International journal of radiation oncology, biology, physics 1989;17(5):915-22.
1989: Berman E; Duigou-Osterndorf R; Krown S E; Fanucchi M P; Chou J; Hirsch M S; Clarkson B D; Chou T C
Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
Blood 1989;74(4):1281-6.
1989: Scheinberg D A; Tanimoto M; McKenzie S; Strife A; Old L J; Clarkson B D
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(6):440-5.
1989: Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(6):446-52.
1989: Tanimoto M; Scheinberg D A; Cordon-Cardo C; Huie D; Clarkson B D; Old L J
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(5):339-48.
1989: Cunningham I; Gee T S; Reich L M; Kempin S J; Naval A N; Clarkson B D
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital.
Blood 1989;73(5):1116-22.
1989: Offit K; Richardson M E; Ceng Q Q; Hampton A; Koduru P R; Jhanwar S C; Filippa D A; Lieberman P H; Clarkson B; Chaganti R S
Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma.
Cancer genetics and cytogenetics 1989;37(1):85-93.
1989: Berman E; Raymond V; Daghestani A; Arlin Z A; Gee T S; Kempin S; Hancock C; Williams L; Stevens Y W; Clarkson B D
4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia.
Cancer research 1989;49(2):477-81.
1989: Berman E; Raymond V; Gee T S; Kempin S J; Gulati S; Andreeff M; Gabrilove J; Young C W; Clarkson B D; Wiernik P H
Idarubicin in acute leukemia: results of US trials.
Bone marrow transplantation 1989;4 Suppl 1():49.
1989: Gulati S C; Gaynor J; Esseesse I; Gee T; Little C; Andreeff M; Berman E; Kempin S; Clarkson B
Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC).
Bone marrow transplantation 1989;4 Suppl 1():86-9.
1989: Gulati S C; Shank B; Sarris A; Berman E; Gee T; Cunningham I; Flomenberg N; O'Reilly R J; Clarkson B
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Bone marrow transplantation 1989;4 Suppl 1():116-8.
1989: Jakubowski A A; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla M A; Moore M A; Gabrilove J
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
The New England journal of medicine 1989;320(1):38-42.
1989: Gulati S C; Shimazaki C; Lemoli R M; Atzpodien J; Clarkson B D
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
European journal of haematology. Supplementum 1989;51():164-72.
1989: Atzpodien J; Bührer C; Gulati S C; Wisniewski D; Oz S; Kirchner H; Benter T; Poliwoda H; Welte K; Clarkson B
Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulation.
Haematology and blood transfusion 1989;32():273-80.
1989: Gulati S C; Kwon J H; Atzpodien J; Triche T J; Colvin O M; Clarkson B D
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation.
Cancer investigation 1989;7(5):411-6.
1989: Gulati S C; Kwon J H; Kushner B; Cheung N K; Atzpodien J; Shum K; Clarkson B D
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamide.
Cancer investigation 1989;7(5):417-22.
1989: Körfer A; Kirchner H; Schneekloth C; Bührer C; Wisniewski D; Gulati S; Clarkson B; Knowles R; Poliwoda H; Atzpodien J
Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.
Acta haematologica 1989;82(4):193-6.
1989: Straus D J; Gaynor J; Myers J; Merke D; Chapman D; Caravelli J; Nisce L Z; Lee B J; Clarkson B D
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():191-6.
1988: Shimazaki C; Wisniewski D; Scheinberg D A; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang C Y; Clarkson B D
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Blood 1988;72(4):1248-54.
1988: Gabrilove J L; Jakubowski A; Fain K; Grous J; Scher H; Sternberg C; Yagoda A; Clarkson B; Bonilla M A; Oettgen H F
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
The Journal of clinical investigation 1988;82(4):1454-61.
1988: Gabrilove J L; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore M A; Clarkson B
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.
Behring Institute Mitteilungen 1988;(83):229-33.
1988: Sokal J E; Gomez G A; Baccarani M; Tura S; Clarkson B D; Cervantes F; Rozman C; Carbonell F; Anger B; Heimpel H
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia.
Blood 1988;72(1):294-8.
1988: Lowenthal D A; Straus D J; Campbell S W; Gold J W; Clarkson B D; Koziner B
AIDS-related lymphoid neoplasia. The Memorial Hospital experience.
Cancer 1988;61(11):2325-37.
1988: Gabrilove J L; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore M A; Clarkson B
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
The New England journal of medicine 1988;318(22):1414-22.
1988: Chadha M; Shank B; Fuks Z; Clarkson B D; Bonfiglio P; Gnecco C; Gulati S
Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation.
International journal of radiation oncology, biology, physics 1988;14(3):407-15.
1988: Strife A; Lambek C; Wisniewski D; Wachter M; Gulati S C; Clarkson B D
Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Cancer research 1988;48(4):1035-41.
1988: Strife A; Clarkson B
Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?
Seminars in hematology 1988;25(1):1-19.
1988: Atzpodien J; Gulati S C; Kwon J H; Kushner B H; Shimazaki C; Bührer C; Oz S; Kolitz J E; Welte K; Clarkson B D
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo.
Experimental cell biology 1988;56(5):236-44.
1988: Atzpodien J; Gulati S C; Shimazaki C; Bührer C; Oz S; Kwon J H; Kolitz J E; Clarkson B D
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
Oncology 1988;45(6):437-43.
1988: Shimazaki C; Atzpodien J; Wisniewski D; Gulati S C; Kolitz J E; Fried J; Clarkson B D
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.
Acta haematologica 1988;80(4):203-9.
1988: Shimazaki C; Gulati S C; Atzpodien J; Fried J; Colvin O M; Clarkson B D
Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213.
Acta haematologica 1988;80(1):17-22.
1988: Gulati S C; Atzpodien J; Langleben A; Shimazaki C; Jain K; Yopp J; Ng R P; Colvin O M; Clarkson B D
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Acta haematologica 1988;80(2):65-70.
1987: Wisniewski D; Strife A; Atzpodien J; Clarkson B D
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Cancer research 1987;47(18):4788-94.
1987: Richardson M E; Chen Q G; Filippa D A; Offit K; Hampton A; Koduru P R; Jhanwar S C; Lieberman P H; Clarkson B D; Chaganti R S
Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes.
Blood 1987;70(2):444-7.
1987: Atzpodien J; Gulati S C; Strife A; Clarkson B D
Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.
Blood 1987;70(2):484-9.
1987: Strife A; Lambek C; Wisniewski D; Gulati S; Gasson J C; Golde D W; Welte K; Gabrilove J L; Clarkson B
Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.
Blood 1987;69(5):1508-23.
1987: Arlin Z A; Liebowitz D; Clarkson B
Pseudo-Philadelphia-positive acute lymphoblastic leukemia (Ph1 + ALL)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):512.
1987: Straus D J; Gaynor J J; Leiberman P H; Filippa D A; Koziner B; Clarkson B D
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
The American journal of medicine 1987;82(2):247-56.
1987: Redman J R; Bajorunas D R; Goldstein M C; Evenson D P; Gralla R J; Lacher M J; Koziner B; Lee B J; Straus D J; Clarkson B D
Semen cryopreservation and artificial insemination for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(2):233-8.
1987: Wisniewski D; Knowles R; Wachter M; Strife A; Clarkson B
Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units.
Blood 1987;69(2):419-29.
1987: Koduru P R; Filippa D A; Richardson M E; Jhanwar S C; Chaganti S R; Koziner B; Clarkson B D; Lieberman P H; Chaganti R S
Cytogenetic and histologic correlations in malignant lymphoma.
Blood 1987;69(1):97-102.
1987: Chang T T; Gulati S; Chou T C; Colvin M; Clarkson B
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.
Cancer research 1987;47(1):119-22.
1987: Andreeff M; Gaynor J; Chapman D; Little C; Gee T; Clarkson B D
Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experience.
Haematology and blood transfusion 1987;30():111-24.
1987: Atzpodien J; Gulati S C; Kwon J H; Wachter M; Fried J; Clarkson B D
Human bone marrow CFU-GM and BFU-E localized by light scatter cell sorting.
Experimental cell biology 1987;55(5):265-70.
1987: Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Natural immunity and cell growth regulation 1987;6(3):129-40.
1987: Fried J; Perez A G; Shimazaki C; Clarkson B D
Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies.
Experimental cell biology 1987;55(6):322-30.
1986: Atzpodien J; Gulati S C; Clarkson B D
Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Cancer research 1986;46(10):4892-5.
1986: Danieu L; Wong G; Koziner B; Clarkson B
Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Cancer research 1986;46(10):5372-9.
1986: Lieberman P H; Filippa D A; Straus D J; Thaler H T; Cirrincione C; Clarkson B D
Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
The American journal of medicine 1986;81(3):365-80.
1986: Arlin Z A; Jhanwar S; Clarkson B
Philadelphia chromosome mosaicism in chronic granulocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(7):1149-50.
1986: Konopka J B; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte O N
Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):4049-52.
1986: Nishikori M; Hansen H; Clarkson B
Inhibition of recovery by actinomycin D from bleomycin-induced potentially lethal damage in a B-lymphoma cell line.
Nippon Gan Chiryo Gakkai shi 1986;21(4):736-43.
1986: Benedetto P; Mertelsmann R; Szatrowski T H; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(4):489-95.
1986: Kennedy B J; Calabresi P; Clarkson B; Frenkel E
Training programs in medical oncology.
Annals of internal medicine 1986;104(2):279.
1986: Kennedy B J; Calabresi P; Clarkson B; Frenkel E
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):269-70.
1986: Mohamed A N; Clarkson B D; Chaganti R S
High resolution banding of chronic myeloid leukemia chromosomes.
Cancer genetics and cytogenetics 1986;20(3-4):209-22.
1986: Gulati S C; Vega R; Gee T; Koziner B; Clarkson B
Growth and development of children born to patients after cancer therapy.
Cancer investigation 1986;4(3):197-205.
1986: Clarkson B D; Gee T; Arlin Z A; Mertelsmann R; Kempin S J; Dinsmore R E; O'Reilly R J; Andreeff M; Berman E; Little C
Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature.
Critical reviews in oncology/hematology 1986;4(3):221-48.
1986: Koziner B; Stavnezer J; Al-Katib A; Gebhard D; Mittelman A; Andreeff M; Clarkson B D
Surface immunoglobulin light chain expression in pre-B cell leukemias.
Annals of the New York Academy of Sciences 1986;468():211-26.
1985: Kennedy B J; Calabresi P; Clarkson B; Frenkel E
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology.
Seminars in oncology 1985;12(4):xxv-xxvi.
1985: Magee M J; McKenzie S; Filippa D A; Arlin Z A; Gee T S; Clarkson B D
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
Cancer 1985;56(11):2557-62.
1985: Nitta M; Kato Y; Strife A; Wachter M; Fried J; Perez A; Jhanwar S; Duigou-Osterndorf R; Chaganti R S; Clarkson B
Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia.
Blood 1985;66(5):1053-61.
1985: Svet-Moldavsky I; Gulati S C; Clarkson B
Growth of human bone marrow in vitro.
Cell biology international reports 1985;9(9):833-40.
1985: Chang T T; Gulati S C; Chou T C; Vega R; Gandola L; Ibrahim S M; Yopp J; Colvin M; Clarkson B D
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Cancer research 1985;45(6):2434-9.
1985: Clarkson B; Ellis S; Little C; Gee T; Arlin Z; Mertelsmann R; Andreeff M; Kempin S; Koziner B; Chaganti R
Acute lymphoblastic leukemia in adults.
Seminars in oncology 1985;12(2):160-79.
1985: Arlin Z A; Mertelsmann R; Berman E; Gee T; Kurland E; Chaganti R S; Jhanwar S C; Moore M A; Clarkson B D
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(4):473-6.
1985: Siena S; Castro-Malaspina H; Gulati S C; Lu L; Colvin M O; Clarkson B D; O'Reilly R J; Moore M A
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow.
Blood 1985;65(3):655-62.
1985: Wisniewski D; Strife A; Wachter M; Clarkson B
Regulation of human peripheral blood erythroid burst-forming unit growth by T lymphocytes and T lymphocyte subpopulations defined by OKT4 and OKT8 monoclonal antibodies.
Blood 1985;65(2):456-63.
1985: Clarkson B
Chronic myelogenous leukemia: is aggressive treatment indicated?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(2):135-9.
1985: Kris M G; Mertelsmann R; Jhanwar S; Chaganti R; Szatrowski T H; Gee T S; Arlin Z; Kempin S; Benedetto P; Clarkson B
Relationship of Auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia.
Leukemia research 1985;9(10):1231-5.
1985: Clarkson B
Summary overview of clinical session.
Haematology and blood transfusion 1985;29():96-101.
1984: Henry S A; Armstrong D; Kempin S; Gee T; Arlin Z; Clarkson B
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
The American journal of medicine 1984;77(4):663-6.
1984: Mertelsmann R; Welte K; Sternberg C; O'Reilly R; Moore M A; Clarkson B D; Oettgen H F
Treatment of immunodeficiency with interleukin-2: initial exploration.
Journal of biological response modifiers 1984;3(5):483-90.
1984: Redman J R; Vugrin D; Arlin Z A; Gee T S; Kempin S J; Godbold J H; Schottenfeld D; Clarkson B D
Leukemia following treatment of germ cell tumors in men.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(10):1080-7.
1984: Al-Katib A; Koziner B; Kurland E; Little C; Labriola D; Thaler H; Straus D; Lee B; Clarkson B
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables.
Cancer 1984;53(11):2404-12.
1984: Blumenreich M S; Woodcock T M; Andreeff M; Hiddemann W; Chou T C; Vale K; O'Hehir M; Clarkson B D; Young C W
Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
Cancer research 1984;44(5):2203-7.
1984: Nishikori M; Hansen H; Jhanwar S; Fried J; Sordillo P; Koziner B; Lloyd K; Clarkson B
Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation.
Cancer genetics and cytogenetics 1984;12(1):39-50.
1984: Sokal J E; Cox E B; Baccarani M; Tura S; Gomez G A; Robertson J E; Tso C Y; Braun T J; Clarkson B D; Cervantes F
Prognostic discrimination in "good-risk" chronic granulocytic leukemia.
Blood 1984;63(4):789-99.
1984: Blumenreich M S; Chou T C; Andreeff M; Vale K; Clarkson B D; Young C W
Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Cancer research 1984;44(2):825-30.
1984: Arlin Z; Kempin S; Mertelsmann R; Gee T; Higgins C; Jhanwar S; Chaganti R S; Clarkson B
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy.
Blood 1984;63(1):211-2.
1983: Jain K; Gulati S; Clarkson B
Modern cancer chemotherapy.
Indian journal of pediatrics 1983;50(407):651-9.
1983: Fried J; Perez A G; Doblin J M; Clarkson B D
Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
Cell and tissue kinetics 1983;16(6):539-48.
1983: Gold E J; Mertelsmann R H; Itri L M; Gee T; Arlin Z; Kempin S; Clarkson B; Moore M A
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.
Cancer treatment reports 1983;67(11):981-6.
1983: Gulati S C; Gulati C; Vega R; Gandola L; Yopp J; Dinsmore R; O'Reilly R; Clarkson B
Non-Hodgkin's lymphoma.
Indian journal of pediatrics 1983;50(407):667-74.
1983: Gulati S C; Vega R; Gandola L; Gulati C; Yopp J; O'Reilly R; Clarkson B
Neuroblastoma.
Indian journal of pediatrics 1983;50(407):661-5.
1983: Jain K; Arlin Z; Mertelsmann R; Gee T; Kempin S; Koziner B; Middleton A; Jhanwar S; Chaganti R; Clarkson B
Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(11):669-76.
1983: Stiff P J; Murgo A J; Wittes R E; DeRisi M F; Clarkson B D
Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation?
Transfusion 1983;23(6):500-3.
1983: Gold E J; Conjalka M; Pelus L M; Jhanwar S C; Broxmeyer H; Middleton A B; Clarkson B D; Moore M A
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(10):627-34.
1983: Blumenreich M S; Strife A; Clarkson B D
A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(9):552-8.
1983: Chaganti R S; Jhanwar S C; Arlin Z; Koziner B; Ambati A; Andreeff M; Clarkson B D
Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomes.
Cancer genetics and cytogenetics 1983;10(1):95-103.
1983: Arlin Z A; Kempin S J; Mertelsmann R; Gee T S; Clarkson B
Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(8):513.
1983: Strife A; Lambek C; Wisniewski D; Arlin Z; Thaler H; Clarkson B
Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients.
Blood 1983;62(2):389-97.
1983: Hiddemann W; Büchner T; Andreeff M; Arlin Z; Wörmann B; Clarkson B D
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]
Onkologie 1983;6(4):179-83.
1983: Svet-Moldavskaya I A; Zinzar S N; Svet-Moldavsky G J; Arlin Z; Vergara C; Koziner B; Clarkson B D; Holland J F
Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(15):4847-50.
1983: Platsoucas C D; Hansen H J; Redman J R; Berenson S; Lee B J; Clarkson B D
T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.
Journal of clinical immunology 1983;3(3):277-84.
1983: Gold E J; Mertelsmann R H; Filippa D A; Szatrowski T H; Koziner B; Clarkson B
Prognostic significance of receptors for the third component of complement an heavy chain phenotype in diffuse B-cell lymphomas.
Blood 1983;62(1):107-11.
1983: Chaganti R S; Jhanwar S C; Koziner B; Arlin Z; Mertelsmann R; Clarkson B D
Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome.
Blood 1983;61(6):1265-8.
1983: Arlin Z; Mertelsmann R; Kempin S; Gee T; Clarkson B
Is further intensification of treatment warranted in acute nonlymphoblastic leukemia?
Cancer treatment reports 1983;67(2):202-4.
1983: Stiff P J; Murgo A J; Zaroulis C G; DeRisi M F; Clarkson B D
Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch.
Cryobiology 1983;20(1):17-24.
1983: Straus D J; Filippa D A; Lieberman P H; Koziner B; Thaler H T; Clarkson B D
The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969.
Cancer 1983;51(1):101-9.
1983: Arlin Z A; Clarkson B D
The treatment of acute nonlymphoblastic leukemia in adults.
Advances in internal medicine 1983;28():303-23.
1983: Straus D J; Myers J; Koziner B; Lee B J; Clarkson B D
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Cancer chemotherapy and pharmacology 1983;11(2):80-5.
1983: Stiff P J; DeRisi M F; Langleben A; Gulati S; Koester A; Lanzotti V; Clarkson B D
Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide.
Annals of the New York Academy of Sciences 1983;411():378-80.
1982: Wisniewski D; Platsoucas C; Strife A; Lambek C; Clarkson B
Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood.
Experimental hematology 1982;10(10):817-29.
1982: Arlin Z A; Fanucchi M P; Gee T S; Kempin S J; Mertelsmann R; Young C W; Clarkson B D
Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).
Blood 1982;60(5):1224-6.
1982: Kempin S; Lee B J; Thaler H T; Koziner B; Hecht S; Gee T; Arlin Z; Little C; Straus D; Reich L; Phillips E; Al-Mondhiry H; Dowling M; Mayer K; Clarkson B
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
Blood 1982;60(5):1110-21.
1982: Platsoucas C D; Galinski M; Kempin S; Reich L; Clarkson B; Good R A
Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):2305-12.
1982: Passe S; Miké V; Mertelsmann R; Gee T S; Clarkson B D
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Cancer 1982;50(8):1462-71.
1982: Koziner B; Gebhard D; Denny T; McKenzie S; Clarkson B D; Miller D A; Evans R L
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies.
Blood 1982;60(3):752-7.
1982: Hiddemann W; Büchner T; Andreeff M; Wörmann B; Melamed M R; Clarkson B D
Cell kinetics in acute leukemia: a critical reevaluation based on new data.
Cancer 1982;50(2):250-8.
1982: Fried J; Doblin J; Takamoto S; Perez A; Hansen H; Clarkson B
Effects of Hoechst 33342 on survival and growth of two tumor cell lines and on hematopoietically normal bone marrow cells.
Cytometry 1982;3(1):42-7.
1982: Koziner B; Little C; Passe S; Thaler H T; Sklaroff R; Straus D J; Lee B J; Clarkson B D
Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables.
Cancer 1982;49(8):1571-9.
1982: Young C W; Straus D J; Myers J; Passe S; Nisce L Z; Lee B J; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson B D
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.
Cancer treatment reports 1982;66(4):907-14.
1982: Goto T; Nishikori M; Arlin Z; Gee T; Kempin S; Burchenal J; Strife A; Wisniewski D; Lambek C; Little C; Jhanwar S; Chaganti R; Clarkson B
Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.
Blood 1982;59(4):793-808.
1982: Chaganti R S; Jhanwar S C; Arlin Z A; Clarkson B D
Chronic myelogenous leukemia in an XYY male.
Cancer genetics and cytogenetics 1982;5(3):223-6.
1982: Chaganti R S; Bailey R B; Jhanwar S C; Arlin Z A; Clarkson B D
Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX).
Cancer genetics and cytogenetics 1982;5(3):215-21.
1982: Hiddemann W; Clarkson B D; Büchner T; Melamed M R; Andreeff M
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia.
Blood 1982;59(2):216-25.
1982: Fried J; Perez A G; Doblin J; Clarkson B D
Effects of cytosine arabinoside and daunorubicin on survival and cell cycle progression of Chinese hamster ovary cells.
Cell and tissue kinetics 1982;15(1):11-23.
1982: Kutti J; Zaroulis C G; Dinsmore R E; Reich L; Clarkson B D; Good R A
A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
Transfusion 1982;22(1):44-7.
1982: Mertelsmann R; Moore M A; Clarkson B
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia.
Blood cells 1982;8(3):561-83.
1982: Hiddemann W; Büchner T; Andreeff M; Wörmann B; Melamed M R; Clarkson B D
Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material.
Leukemia research 1982;6(4):601-12.
1981: Schauer P K; Straus D J; Bagley C M; Rudolph R H; McCracken J D; Huff J; Glucksburg H; Bauermeister D E; Clarkson B D
Angioimmunoblastic lymphadenopathy: clinical spectrum of disease.
Cancer 1981;48(11):2493-8.
1981: Clarkson B D
The elusive goal: presidential address.
Cancer research 1981;41(12 Pt 1):4865-84.
1981: Clarkson B
Results of intensive treatment of chronic myelogenous leukemia.
Nippon Ketsueki Gakkai zasshi : journal of Japan Haematological Society 1981;44(7):1263-76.
1981: Svet-Moldavskaya I A; Arlin Z; Svet-Moldavsky G J; Clarkson B D; Koziner B; Mendelsohn N; Zinzar S N; Holland J F
Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells.
Cancer research 1981;41(11 Pt 1):4335-40.
1981: Mertelsmann R; Moore M A; Broxmeyer H E; Cirrincione C; Clarkson B
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4844-8.
1981: Mertelsmann R; Drapkin R L; Gee T S; Kempin S; Passe S; Thaler H T; Arlin Z; Dowling M; Dufour P; McKenzie S; To L; Comacho E; Oettgen H F; Burchenal J H; Clarkson B
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Cancer 1981;48(10):2136-42.
1981: Svet-Moldavskaya I A; Svet-Moldavsky G J; Zinzar S N; Holland J F; Vergara C; Arlin Z; Koziner B; Clarkson B D
Induction of giant fat cells in human bone marrow culture by human serum factor.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(5):141-2.
1981: Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(5):142-4.
1981: Straus D J; Lee B J; Koziner B; Nisce L Z; Young C W; Clarkson B D
The treatment of advanced hodgkin's disease.
Blut 1981;43(2):119-24.
1981: Fried J; Perez A G; Doblin J M; Clarkson B D
Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
Cancer research 1981;41(7):2627-32.
1981: Hansen H; Koziner B; Clarkson B
Marker and kinetic studies in the non-Hodgkin's lymphomas.
The American journal of medicine 1981;71(1):107-23.
1981: Singer J W; Adamson J W; Arlin Z A; Kempin S J; Clarkson B D; Fialkow P J
Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy.
The Journal of clinical investigation 1981;67(6):1593-8.
1981: Yen A; Lambek C; Clarkson B
Inaccuracy of estimations of s phase fraction by reduction in cloning efficiency with hydroxyurea or tritiated thymidine.
Cell and tissue kinetics 1981;14(3):301-8.
1981: Friedman A; Schauer P; Mertelsmann R; Cirrincione C; Thaler H; Dufour P; Ellis S B; Teitelbaum H; Kempin S; Gee T S; Arlin Z; Clarkson B
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission.
Blood 1981;57(4):798-801.
1981: Fried J; Perez A G; Doblin J M; Clarkson B D
Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture.
Cancer research 1981;41(3):1127-32.
1981: Straus D J; Passe S; Koziner B; Lee B J; Young C W; Clarkson B D
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature.
Cancer treatment reports 1981;65(3-4):207-11.
1981: Fried J; Perez A G; Doblin J; Clarkson B D
Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.
Cancer treatment reports 1981;65(1-2):153-6.
1981: Hiddemann W; Andreeff M; Clarkson B D
Quantitation of chemotherapy-induced cytoreduction in acute leukemia.
Haematology and blood transfusion 1981;26():73-6.
1981: Nishikori M; Hansen H; Yen A; Clarkson B
Cloning of fresh lymphoma cells.
Medical and pediatric oncology 1981;9(2):167-73.
1981: Mertelsmann R; Moore M A; Clarkson B
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells.
Haematology and blood transfusion 1981;26():68-72.
1981: Arlin Z A; Flomenberg N; Gee T S; Kempin S J; Dellaquila C; Mertelsmann R; Straus D J; Young C W; Clarkson B D
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
Cancer clinical trials 1981;4(3):317-21.
1980: Straus D J; Mertelsmann R; Koziner B; McKenzie S; de Harven E; Arlin Z A; Kempin S; Broxmeyer H; Moore M A; Menendez-Botet C J; Gee T S; Clarkson B D
The acute monocytic leukemias: multidisciplinary studies in 45 patients.
Medicine 1980;59(6):409-25.
1980: Koziner B; Kempin S; Passe S; Gee T; Good R A; Clarkson B D
Characterization of B-cell leukemias: a tentative immunomorphological scheme.
Blood 1980;56(5):815-23.
1980: Mertelsmann R; Tzvi Thaler H; To L; Gee T S; McKenzie S; Schauer P; Friedman A; Arlin Z; Cirrincione C; Clarkson B
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia.
Blood 1980;56(5):773-81.
1980: Arlin Z A; Sklaroff R B; Gee T S; Kempin S J; Howard J; Clarkson B D; Young C W
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
Cancer research 1980;40(9):3304-6.
1980: Singer J W; Arlin Z A; Najfeld V; Adamson J W; Kempin S J; Clarkson B D; Fialkow P J
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome.
Blood 1980;56(3):356-60.
1980: Platsoucas C D; Fernandes G; Gupta S L; Kempin S; Clarkson B; Good R A; Gupta S
Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(3):1216-23.
1980: Gulati S C; Mertelsmann R; Gee T; Good R A; Clarkson B; Moore M A; Koziner B
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease.
Cancer 1980;46(4):725-9.
1980: Schulof R S; Lee B J; Lacher M J; Straus D J; Clarkson B D; Good R A; Gupta S
Concanavalin A-induced suppressor cell activity in Hodgkin's disease.
Clinical immunology and immunopathology 1980;16(4):454-62.
1980: Andreeff M; Clarkson B D
[Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment]
Der Internist 1980;21(7):371-5.
1980: Pelus L M; Broxmeyer H E; Clarkson B D; Moore M A
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Cancer research 1980;40(7):2512-5.
1980: Haghbin M; Murphy M L; Tan C C; Clarkson B D; Thaler H T; Passe S; Burchenal J
A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens.
Cancer 1980;46(2):241-52.
1980: Beck J D; Haghbin M; Wollner N; Mertelsmann R; Garrett T; Koziner B; Clarkson B; Miller D; Good R A; Gupta S
Subpopulations of human T lymphocytes. VI. Analysis of cell markers in acute lymphoblastic leukemia with special reference to Fc receptor expression on E-rosette-forming blasts.
Cancer 1980;46(1):45-9.
1980: Straus D J; Myers J; Passe S; Young C W; Nisce L Z; Lee B J; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson B D
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Cancer 1980;46(2):233-40.
1980: Beck J D; Koziner B; Mertelsmann R; Platsoucas C D; Clarkson B; Good R A
B cells from a patient with chronic lymphocytic leukemia bind to sheep erythrocytes: an immunological analysis.
Clinical immunology and immunopathology 1980;16(2):233-7.
1980: Gulati S C; Sordillo P; Kempin S; Reich L; Magill G B; Scheiner E; Clarkson B
Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
Cancer 1980;45(9):2252-7.
1980: Dinsmore R E; Straus D J; Pollack M S; Woodruff J M; Garrett T J; Young C W; Clarkson B D; Dupont B
Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
Blood 1980;55(5):831-4.
1980: Murgo A J; Fried J; Burchenal D; Vale K L; Strife A; Woodcock T; Young C W; Clarkson B D
Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.
Cancer research 1980;40(5):1543-9.
1980: Platsoucas C D; Kempin S; Karanas A; Clarkson B; Good R A; Gupta S
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.
Clinical and experimental immunology 1980;40(2):256-63.
1980: Phillips E A; Kempin S; Reich L; Clarkson B
Bleomycin for treatment of immune cytopenia.
The New England journal of medicine 1980;302(18):1031.
1980: Garrett T J; Grossbard E; Hopfan S; Koziner B; Clarkson B D; Good R A; O'Reilly R
Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemia.
Cancer 1980;45(8):2006-8.
1980: Koziner B; Mertelsmann R; Andreeff M; Arlin Z; Hansen H; De Harven E; McKenzie S; Gee T; Good R A; Clarkson B
Heterogeneity of cell lineages in L3 leukemias.
Blood 1980;55(4):694-8.
1980: Fried J; Perez A G; Clarkson B
Quantitative analysis of cell cycle progression of synchronous cells by flow cytometry.
Experimental cell research 1980;126(1):63-74.
1980: Andreeff M; Darzynkiewicz Z; Sharpless T K; Clarkson B D; Melamed M R
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA.
Blood 1980;55(2):282-93.
1980: Straus D J; Young C W; Lee B J; Koziner B; Clarkson B D; Nisce L Z
The treatment of advanced Hodgkin's disease at Memorial Hospital.
Clinical bulletin 1980;10(4):138-43.
1980: Modak M J; Mertelsmann R; Koziner B; Pahwa R; Moore M A; Clarkson B D; Good R A
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.
Journal of cancer research and clinical oncology 1980;98(1):91-104.
1980: Kutti J; Zaroulis C G; Kulpa J; Reich L; Clarkson B D; Good R A
Plasma beta-thromboglobulin values in thrombocytopenic patients with acute leukemia.
American journal of hematology 1980;8(4):339-45.
1979: Svet-Moldavskaya I A; Zinzar S N; Svet-Moldavsky G J; Mann P E; Bekesi J G; Holland J F; Clarkson B D; Arlin Z; Koziner B
Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1979;31(9-10):252-7.
1979: Straus D J; Andreeff M; Hansen H J; Mertelsmann R; Koziner B; Chaganti R; Gee T S; McKenzie S; Melamed M R; Clarkson B D
The coexistence of acute myeloblastic leukemia and diffuse histiocytic lymphoma in the same patient as demonstrated by multiparameter analysis.
Blood 1979;54(6):1428-33.
1979: Cunningham I; Gee T; Dowling M; Chaganti R; Bailey R; Hopfan S; Bowden L; Turnbull A; Knapper W; Clarkson B
Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).
Blood 1979;53(3):375-95.
1979: Koziner B; KEmpin S; Gee T; Lee B J; Good R A; Clarkson B D
Cell-marker analysis of complete remissions in chronic B-cell leukaemias.
Lancet 1979;1(8108):158.
1979: Mertelsmann R; Koziner B; Filippa D A; Grossbard E; Incefy G; Moore M A; Clarkson B D
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
Haematology and blood transfusion 1979;23():131-8.
1979: Mertelsmann R; Filippa D A; Koziner B; Grossbard E; Beck J; Moore M A; Lieberman P H; Clarkson B D; Gupta S; Good R A
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas.
Advances in experimental medicine and biology 1979;114():553-60.
1979: Svet-Moldavskii G Ia; Khollend J F; Svet-Moldavskii I A; Clarkson B D
[Differentiation of human normal and leukemic bone marrow and blood cells in tissue culture upon exposure to a tumor promotor]
Doklady Akademii nauk SSSR 1979;249(3):720-2.
1979: Drapkin R L; Adreeff M; Koziner B; Strife A; Wisniewski D; Darzynkiewicz Z; Melamed M R; Clarkson B
Subpopulations of human peripheral blood cells: analysis of granulocytic progenitor cells by flow cytometry and immunologic surface markers.
American journal of hematology 1979;7(2):163-72.
1978: Fried J; Perez A G; Clarkson B D
Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1978;26(11):921-33.
1978: Gee T S; Cunningham I; Dowling M D; Chaghanti R; Clarkson B D
The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia.
Bollettino dell'Istituto sieroterapico milanese 1978;57(3):289-93.
1978: Arlin Z A; Fried J; Clarkson B D
Therapeutic role of cell kinetics in acute leukaemia.
Clinics in haematology 1978;7(2):339-62.
1978: Drapkin R L; Gee T S; Dowling M D; Arlin Z; McKenzie S; Kempin S; Clarkson B
Prophylactic heparin therapy in acute promyelocytic leukemia.
Cancer 1978;41(6):2484-90.
1978: Mertelsmann R; Koziner B; Ralph R; Filippa D; McKenzie S; Arlin Z A; Gee T S; Moore M A; Clarkson B D
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.
Blood 1978;51(6):1051-6.
1978: Clarkson B D
Current concepts of leukemia and results of recent treatment programs.
Transplantation proceedings 1978;10(1):157-62.
1977: Case D C; Lee D J; Clarkson B D
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
The American journal of medicine 1977;63(6):897-903.
1977: Clarkson B D; Fried J; Chou T C; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
Duration of the dormant state in an established cell line of human hematopoietic cells.
Cancer research 1977;37(12):4506-22.
1977: Chou T C; Arlin Z; Clarkson B D; Phillips F S
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
Cancer research 1977;37(10):3561-70.
1977: Koziner B; Filippa D A; Mertelsmann R; Gupta S; Clarkson B; Good R A; Siegal F P
Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology.
The American journal of medicine 1977;63(4):556-67.
1977: Garrett T J; Takahashi T; Clarkson B D; Old L J
Detection of antibody to autologous human leukemia cells by immune adherence assays.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(10):4587-90.
1977: Yen A; Fried J; Clarkson B
Alternative modes of population growth inhibition in a human lymphoid cell line growing in suspension.
Experimental cell research 1977;107(2):325-41.
1977: Koziner B; McKenzie S; Straus D; Clarkson B; Good R A; Siegal F P
Cell marker analysis in acute monocytic leukemias.
Blood 1977;49(6):895-901.
1977: Nicolini C; Kendall F; Baserga R; Dessaive C; Clarkson B; Fried J
The G0-G1 transition of WI38 cells. I. Laser flow microfluorimetric studies.
Experimental cell research 1977;106(1):111-8.
1977: Arlin Z A; Chiao J W; Fried J; Dowling M D; Clarkson B D; Good R A
Relationship of a T-lymphocyte marker to phase of cell cycle and morphology of leukemic cells.
Cancer 1977;39(3):1101-4.
1977: Phillips E A; Kempin S; Passe S; Miké V; Clarkson B
Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy.
Clinics in haematology 1977;6(1):203-22.
1977: Garrett T J; Gee T S; Dowling M D; Lee B J; Middleman M P; Clarkson B D; Young C W
Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphoma.
Cancer treatment reports 1977;61(1):7-16.
1976: Garrett T J; Gee T S; Lieberman P H; McKenzie S; Clarkson B D
The role of bone marrow aspiration and biopsy in detecting marrow involvement by nonhematologic malignancies.
Cancer 1976;38(6):2401-3.
1976: Fried J; Arlin Z; Alikpala A; Tan C T; Clarkson B
Kinetic response of human leukemic and lymphoma cells in vivo to combination chemotherapy using flow microfluorometry.
Cancer treatment reports 1976;60(12):1937-46.
1976: Nicolini C; Kendall F; Desaive C; Baserga R; Clarkson B; Fried J
Physical-chemical characterization of living cells by laser-flow microfluorometry.
Cancer treatment reports 1976;60(12):1819-27.
1976: Fried J; Perez A G; Clarkson B D
Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data.
The Journal of cell biology 1976;71(1):172-81.
1976: Case D C; Young C W; Nisce L; Lee B J; Clarkson B D
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Cancer treatment reports 1976;60(9):1217-23.
1976: Fried J; Yataganas X; Kitahara T; Perez A; Ferguson R; Sullivan S; Clarkson B
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations.
Computers and biomedical research, an international journal 1976;9(3):277-90.
1976: Gee T S; Haghbin M; Dowling M D; Cunningham I; Middleman M P; Clarkson B D
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
Cancer 1976;37(3):1256-64.
1976: Yataganas X; Strife A; Perez A; Clarkson B
Cell kill kinetics with hydroxyurea.
Medical and pediatric oncology 1976;2(1):39-54.
1975: Polliack A; Siegal F P; Clarkson B D; Fu S M; Winchester R J; Lampen N; Siegal M; De Harven E
A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders.
Scandinavian journal of haematology 1975;15(5):359-76.
1975: Yen A; Fried J; Kitahara T; Strife A; Clarkson B D
The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase.
Experimental cell research 1975;95(2):303-10.
1975: Yen A; Fried J; Kitahara T; Stride A; Clarkson B D
The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis.
Experimental cell research 1975;95(2):295-302.
1975: Polliack A; McKenzie S; Gee T; Lampen N; de Harven E; Clarkson B D
A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia.
The American journal of medicine 1975;59(3):308-15.
1975: Clarkson B D; Dowling M D; Gee T S; Cunningham I B; Burchenal J H
Treatment of acute leukemia in adults.
Cancer 1975;36(2):775-95.
1975: Sheehy P F; Fried J; Dowling M D; Clarkson B D
Studies of cellular proliferation in human leukemia. VIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease.
Cancer 1975;36(1):203-10.
1975: Kuo A H; Yataganas X; Galicich J H; Fried J; Clarkson B D
Proliferative kinetics of central nervous system (CNS) leukemia.
Cancer 1975;36(1):232-9.
1975: Haghbin M; Tan C T; Clarkson B D; Miké V; Burchenal J H; Murphy M L
Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Cancer research 1975;35(3):807-11.
1975: Yataganas X; Mitomo Y; Traganos F; Strife A; Clarkson B
Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique.
Acta cytologica 1975;19(1):71-8.
1974: Yataganas X; Strife A; Perez A; Clarkson B D
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine.
Cancer research 1974;34(10):2795-806.
1974: Polliack A; Lampen N; Clarkson B; De Harven E
Scanning electron microscopy of human leukocytes. A comparison of air dried and critical point dried cells.
Israel journal of medical sciences 1974;10(9):1075-85.
1974: Fried J; Friedman H; Zietz S; Todo A; Strife A; Clarkson B D
Computer analysis of tracer kinetic data from a human hematopoietic cell line during different phases of growth.
Computers and biomedical research, an international journal 1974;7(4):333-59.
1974: Yataganas X; Clarkson B D
Flow microfluorometric analysis of cell killing with cytotoxic drugs.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1974;22(7):651-9.
1974: Haghbin M; Tan C C; Clarkson B D; Miké V; Burchenal J H; Murphy M L
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Cancer 1974;33(6):1491-8.
1974: Sheehy P F; Wakonig-Vaartaja T; Winn R; Clarkson B D
Asynchronous DNA synthesis and asynchronous mitosis in multinuclear ovarian cancer cells.
Cancer research 1974;34(5):991-6.
1974: Lee B J; Sahakian G; Clarkson B D; Krakoff I H
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
Cancer 1974;33(2):533-8.
1974: Sheehy P F; Fried J; Winn R; Clarkson B D
Cell cycle changes in ovarian cancer after arabinosylcytosine.
Cancer 1974;33(1):28-37.
1973: Polliack A; Lampen N; Clarkson B D; De Harven E; Bentwich Z; Siegal F P; Kunkel H G
Identification of human B and T lymphocytes by scanning electron microscopy.
The Journal of experimental medicine 1973;138(3):607-24.
1973: Monfardini S; Gee T; Fried J; Clarkson B
Survival in chronic myelogenous leukemia: influence of treatment and extent of disease at diagnosis.
Cancer 1973;31(3):492-501.
1973: Dowling M D; Haghbin M; Gee T S; Cunningham B; Tan C T; Clarkson B D; Burchenal J H
Comparative results obtained in the treatment of acute leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1973;43():133-44.
1973: Clarkson B D; Dowling M D; Gee T S; Burchenal J H
Treatment of acute myeloblastic leukemia.
Bibliotheca haematologica 1973;39():1098-114.
1973: Tan C; Haghbin M; Gee T; Clarkson B; Murphy M L
Combination therapy involving L-asparaginase in acute leukemia.
Bibliotheca haematologica 1973;39():1074-84.
1972: Clarkson B D
Acute myelocytic leukemia in adults.
Cancer 1972;30(6):1572-82.
1971: Todo A; Strife A; Fried J; Clarkson B D
Proliferative kinetics of human hematopoietic cells during different growth phases in vitro.
Cancer research 1971;31(10):1330-40.
1971: Ohara K; Fried J; Dowling M D; Bittar E S; Clarkson B D
Studies on cellular proliferation in human leukemia. VII. Cytokinetic behavior of neoplastic cells in a patient with reticulum cell sarcoma in a leukemic phase.
Cancer 1971;28(4):862-85.
1971: Myers W P; Krakoff I H; Clarkson B D
The training of internists in cancer.
The Medical clinics of North America 1971;55(3):647-52.
1971: Clarkson B D; Fried J
Changing concepts of treatment in acute leukemia.
The Medical clinics of North America 1971;55(3):561-600.
1971: Clarkson B D; Boyse E A
Possible explanation of the high concoddance for acute leukaemia in monozygotic twins.
Lancet 1971;1(7701):699-701.
1971: Knight S C; Moore G E; Clarkson B D
Stimulation of autochthonous lymphocytes by cells from normal and leukaemic lines.
Nature: New biology 1971;229(6):185-7.
1970: Clarkson B; Strife A; Fried J; Sakai Y; Ota K; Ohkita T; Masuda R
Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days.
Cancer 1970;26(1):1-19.
1970: Clarkson B; Fried J; Strife A; Sakai Y; Ota K; Okita T
Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days.
Cancer 1970;25(6):1237-60.
1970: Ogawa M; Fried J; Sakai Y; Strife A; Clarkson B D
Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia.
Cancer 1970;25(5):1031-49.
1970: Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
Cancer 1970;25(2):279-305.
1970: Oettgen H F; Stephenson P A; Schwartz M K; Leeper R D; Tallai L; Tan C C; Clarkson B D; Golbey R B; Krakoff I H; Karnofsky D A; Murphy M L; Burchenal J H
Toxicity of E. coli L-asparaginase in man.
Cancer 1970;25(2):253-78.
1970: Oettgen H F; Tallal L; Tan C C; Murphy M L; Clarkson B D; Golbey R D; Krakoff I H; Karnofsky D A; Burchenal H J
Clinical experience with L-asparaginase.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1970;33():219-35.
1969: Southam C M; Burchenal J H; Clarkson B; Tanzi A; Mackey R; McComb V
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats.
Cancer 1969;24(2):211-22.
1969: Clarkson B D
Review of recent studies of cellular proliferation in acute leukemia.
National Cancer Institute monograph 1969;30():81-120.
1969: Gee T S; Yu K P; Clarkson B D
Treatment of adult acute leukemia with arabinosylcytosine and thioguanine.
Cancer 1969;23(5):1019-32.
1969: Clarkson B D; Thorbecke G J; de Harven E; Miles C
Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and during long-term culture in vitro.
Cancer research 1969;29(4):823-36.
1969: Southam C M; Burchenal J H; Clarkson B; Tanzi A; Mackey R; McComb V
Hetero- transplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats.
Cancer 1969;23(2):281-99.
1968: Miles C P; O'Neill F; Armstrong D; Clarkson B; Keane J
Chromosome patterns of human leukocyte established cell lines.
Cancer research 1968;28(3):481-90.
1967: Oettgen H F; Old L J; Boyse E A; Campbell H A; Philips F S; Clarkson B D; Tallal L; Leeper R D; Schwartz M K; Kim J H
Inhibition of leukemias in man by L-asparaginase.
Cancer research 1967;27(12):2619-31.
1967: Clarkson B
Formal discussion: on the cellular origins and distinctive features of cultured cell lines derived from patients with leukemias and lymphomas.
Cancer research 1967;27(12):2483-8.
1967: Van Dyk J J; Clarkson B D; Duschinsky R; Keller O; La Sala E; Krakoff I H
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Cancer research 1967;27(11):2129-36.
1967: Clarkson B; Strife A; De Harven E
Continuous culture of seven new cell lines (SK-L1 to 7) from patients with acute leukemia.
Cancer 1967;20(6):926-47.
1967: De Harven E; Clarkson B; Strife A
Electron microscopic study of human leukemic cells in tissue culture.
Cancer 1967;20(6):911-25.
1967: Clarkson B; Ohkita T; Ota K; Fried J
Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.
The Journal of clinical investigation 1967;46(4):506-29.
1965: Clarkson B; Ota K; Ohkita T; O'Connor A
Kinetics of proliferation of cancer cells in neoplastic effusions in man.
Cancer 1965;18(10):1189-213.
1965: WANEBO H J; CLARKSON B D
ESSENTIAL MACROGLOBULINEMIA. REPORT OF A CASE INCLUDING IMMUNOFLUORESCENT AND ELECTRON MICROSCOPIC STUDIES.
Annals of internal medicine 1965;62():1025-45.
1965: CLARKSON B D; BURCHENAL J H
PROGRESS IN LEUKEMIAS.
Progress in clinical cancer 1965;10():625-63.
1964: CLARKSON B
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
Cancer 1964;17():914-28.
1964: CLARKSON B; KATZ A; DANN M A; KARNOFSKY D A
BEHAVIOR OF P388 MOUSE LEUKEMIA IN THE CHICK EMBRYO AND HATCHED CHICK.
Journal of the National Cancer Institute 1964;32():471-95.
1962: MORI S; CLARKSON B; O'CONNOR A; LAWRENCE W
Experimental perfusion system utilizing the rabbit Vx-2 carcinoma. III. Correlative studies of in vitro sterilization of Vx-2 cells with results of perfusions in rabbits and in patients.
Clinical pharmacology and therapeutics 1962;3():447-63.
1962: MORI S; CLARKSON B; MASLE E T; LAWRENCE W
An experimental perfusion system using the rabbit Vx-2 carcinoma. i. Studies on the effect of drug perfusions and irradiation.
The Journal of surgical research 1962;2():268-82.
1962: CLARKSON B; YOUNG C; DIERICK W; KUEHN P; KIM M; BERRETT A; CLAPP P; LAWRENCE W
Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver.
Cancer 1962;15():472-88.
1961: DUFF J K; SULLIVAN R D; MILLER E; ULM A H; CLARKSON B D; CLIFFORD P
Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
Cancer 1961;14():744-52.
1961: CLARKSON B; LAWRENCE W
Perfusion and infusion techniques in cancer chemotherapy.
The Medical clinics of North America 1961;45():689-710.

Sign-in to see more